ZIVO (Zivo Bioscience) LT-Debt-to-Total-Asset: 0.42 (As of Sep. 2025)


ZIVO Zivo Bioscience Inc ZIVO
8 GF Score
Price $5.25
! 5 Warning Signs
View Full Analysis

What is Zivo Bioscience LT-Debt-to-Total-Asset?

Zivo Bioscience ZIVO 8 LT-Debt-to-Total-Asset is 0.42 as of Sep. 2025. GuruFocus rates ZIVO with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Zivo Bioscience's long-term debt to total assests ratio for the quarter that ended in Sep. 2025 was 0.42.

Zivo Bioscience's long-term debt to total assets ratio increased from Sep. 2024 (0.00) to Sep. 2025 (0.42). It may suggest that Zivo Bioscience is progressively becoming more dependent on debt to grow their business.

Zivo Bioscience  (OTCPK:ZIVO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Zivo Bioscience LT-Debt-to-Total-Asset Related Terms

Zivo Bioscience LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Zivo Bioscience's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zivo Bioscience LT-Debt-to-Total-Asset Chart

Zivo Bioscience Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.62 0.00 0.05 0.00 0.07

Zivo Bioscience Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.07 0.25 0.40 0.42
ZIVO
8GF Score
Zivo Bioscience Inc ZIVO
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zivo Bioscience LT-Debt-to-Total-Asset Calculation

Zivo Bioscience's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )/Total Assets (A: Dec. 2024 )
=0.116/1.643
=0.07

Zivo Bioscience's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2025 is calculated as

LT Debt to Total Assets (Q: Sep. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2025 )/Total Assets (Q: Sep. 2025 )
=0.232/0.559
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.42 mean?
Zivo Bioscience (ZIVO) has a LT-Debt-to-Total-Asset of 0.42 as of Sep. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Zivo Bioscience and its competitors.
Is Zivo Bioscience's LT-Debt-to-Total-Asset too high?
Zivo Bioscience's current LT-Debt-to-Total-Asset is 0.42. Overall, Zivo Bioscience has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's LT-Debt-to-Total-Asset compare to ATOS and QNCX?
Zivo Bioscience's LT-Debt-to-Total-Asset of 0.42 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Zivo Bioscience and its competitors. Zivo Bioscience's current LT-Debt-to-Total-Asset is 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current LT-Debt-to-Total-Asset of 0.42. The current LT-Debt-to-Total-Asset is 0.42. Zivo Bioscience's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current LT-Debt-to-Total-Asset is 0.42 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zivo Bioscience Business Description

Address 2125 Butterfield Drive, Suite 100, Troy, MI, USA, 48084
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
8GF Score

Get the complete analysis for ZIVO

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.25
Price